Cargando…

Detection of prostate cancer by an FDG-PET cancer screening program: results from a Japanese nationwide survey

OBJECTIVE(S): The aim of this study was to analyze detection rates and effectiveness of (18)F-fluorodeoxyglucose positron emission tomography (FDG-PET) cancer screening program for prostate cancer in Japan, which is defined as a cancer-screening program for subjects without known cancer. It contains...

Descripción completa

Detalles Bibliográficos
Autores principales:	Minamimoto, Ryogo, Senda, Michio, Jinnouchi, Seishi, Terauchi, Takashi, Inoue, Tomio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Asia Oceania Journal of Nuclear Medicine & Biology 2014
Materias:	Short Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4937707/ https://www.ncbi.nlm.nih.gov/pubmed/27408855

Ejemplares similares

The current status of an FDG-PET cancer screening program in Japan, based on a 4-year (2006–2009) nationwide survey
por: Minamimoto, Ryogo, et al.
Publicado: (2012)

Series of myocardial FDG uptake requiring considerations of myocardial abnormalities in FDG-PET/CT
por: Minamimoto, Ryogo
Publicado: (2021)

Japanese guideline for the oncology FDG-PET/CT data acquisition protocol: synopsis of Version 2.0
por: Fukukita, Hiroyoshi, et al.
Publicado: (2014)

Optimal use of the FDG-PET/CT in the diagnostic process of fever of unknown origin (FUO): a comprehensive review
por: Minamimoto, Ryogo
Publicado: (2022)

Prognostic value of FDG-PET radiomics with machine learning in pancreatic cancer
por: Toyama, Yoshitaka, et al.
Publicado: (2020)

Imaging patients with breast and prostate cancers using combined 18F NaF/18F FDG and TOF simultaneous PET/ MRI
por: Iagaru, Andrei, et al.
Publicado: (2015)

Diagnostic performance of (18)F-FDG PET/CT using point spread function reconstruction on initial staging of rectal cancer: a comparison study with conventional PET/CT and pelvic MRI
por: Hotta, Masatoshi, et al.
Publicado: (2018)

Present and future roles of FDG-PET/CT imaging in the management of gastrointestinal cancer: an update
por: Kitajima, Kazuhiro, et al.
Publicado: (2017)

Comparison of (11)C-4′-thiothymidine, (11)C-methionine, and (18)F-FDG PET/CT for the detection of active lesions of multiple myeloma
por: Okasaki, Momoko, et al.
Publicado: (2014)

Proliferation PET/CT Imaging of Salivary Gland Tumor
por: Minamimoto, Ryogo
Publicado: (2021)

Prognostic Value of Quantitative Metabolic Metrics on Baseline Pre-Sunitinib FDG PET/CT in Advanced Renal Cell Carcinoma
por: Minamimoto, Ryogo, et al.
Publicado: (2016)

Cell Proliferation PET Imaging with 4DST PET/CT in Colorectal Adenocarcinoma and Adenoma
por: Minamimoto, Ryogo, et al.
Publicado: (2021)

The acceleration of glucose accumulation in renal cell carcinoma assessed by FDG PET/CT demonstrated acquisition of resistance to tyrosine kinase inhibitor therapy
por: Nakaigawa, Noboru, et al.
Publicado: (2017)

FDG PET/CT as a prognostic biomarker in the era of molecular-targeting therapies: max SUVmax predicts survival of patients with advanced renal cell carcinoma
por: Nakaigawa, Noboru, et al.
Publicado: (2016)

(18)F-FDG and (11)C-4DST PET/CT for evaluating response to platinum-based doublet chemotherapy in advanced non-small cell lung cancer: a prospective study
por: Minamimoto, Ryogo, et al.
Publicado: (2019)

Early assessment by FDG-PET/CT of patients with advanced renal cell carcinoma treated with tyrosine kinase inhibitors is predictive of disease course
por: Ueno, Daiki, et al.
Publicado: (2012)

The early response of renal cell carcinoma to tyrosine kinase inhibitors evaluated by FDG PET/CT was not influenced by metastatic organ
por: Kakizoe, Manabu, et al.
Publicado: (2014)

Detection of primary sites in unknown primary tumors using FDG-PET or FDG-PET/CT
por: Park, Jong Sun, et al.
Publicado: (2011)

Lesion-based analysis of (18)F-FDG uptake and (111)In-Pentetreotide uptake by neuroendocrine tumors
por: Kubota, Kazuo, et al.
Publicado: (2014)

FDG-PET Versus PSMA-PET: A Patient With Prostate Cancer
por: Kichloo, Asim, et al.
Publicado: (2020)

Phantom criteria for qualification of brain FDG and amyloid PET across different cameras
por: Ikari, Yasuhiko, et al.
Publicado: (2016)

Prediction of EGFR and KRAS mutation in non-small cell lung cancer using quantitative (18)F FDG-PET/CT metrics
por: Minamimoto, Ryogo, et al.
Publicado: (2017)

11C-methionine-PET for differentiating recurrent brain tumor from radiation necrosis: radiomics approach with random forest classifier
por: Hotta, Masatoshi, et al.
Publicado: (2019)

The potential of TOF PET-MRI for reducing artifacts in PET images
por: Iagaru, Andrei, et al.
Publicado: (2015)

The Values and Limitations of FDG-PET/CT for Diagnosis of Hibernoma
por: Park, Jong Hoon, et al.
Publicado: (2015)

Conspicuity of Malignant Lesions on PET/CT and Simultaneous Time-Of-Flight PET/MRI
por: Minamimoto, Ryogo, et al.
Publicado: (2017)

Impact of maximum Standardized Uptake Value (SUVmax) evaluated by 18-Fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography ((18)F-FDG-PET/CT) on survival for patients with advanced renal cell carcinoma: a preliminary report
por: Namura, Kazuhiro, et al.
Publicado: (2010)

Association of body mass index and height with risk of prostate cancer among middle-aged Japanese men
por: Kurahashi, N, et al.
Publicado: (2006)

FDG-PET in colorectal cancer
por: de Geus-Oei, Lioe-Fee, et al.
Publicado: (2006)

FDG-PET and colon cancer
por: Miles, Ken
Publicado: (2015)

Neurocognitive dysfunction and brain FDG-PET/CT findings in HIV-infected hemophilia patients and HIV-infected non-hemophilia patients
por: Imai, Koubun, et al.
Publicado: (2020)

Metastasizing pleomorphic adenoma in the multiple organs: A case report on FDG-PET/CT imaging
por: Koyama, Masamichi, et al.
Publicado: (2018)

Oncology and cardiology positron emission tomography/computed tomography faced with COVID-19: A review of available literature data
por: Minamimoto, Ryogo
Publicado: (2022)

A Japanese Nationwide Survey of Nutritional Counseling for Cancer Patients and Risk Factors of Burnout among Registered Dietitians
por: Chitose, Haruka, et al.
Publicado: (2022)

Pitfalls of FDG-PET in the prostate for the surgical oncologist
por: O'Connor, Ellen, et al.
Publicado: (2020)

The Effect of Endogenous Adenosine on Neuronal Activity in Rats: An FDG PET Study
por: Parkinson, Fiona E., et al.
Publicado: (2016)

Tiny Obturator Node Metastasis from Prostate Cancer Not Shown by FDG-PET/CT, CT, or MRI Detected by (11)C-Choline PET/CT
por: Kitajima, Kazuhiro, et al.
Publicado: (2018)

Current status of radioligand therapy and positron-emission tomography with prostate-specific membrane antigen
por: Inubushi, Masayuki, et al.
Publicado: (2020)

Initial evaluation of the Celesteion large-bore PET/CT scanner in accordance with the NEMA NU2-2012 standard and the Japanese guideline for oncology FDG PET/CT data acquisition protocol version 2.0
por: Kaneta, Tomohiro, et al.
Publicado: (2017)

Sinonasal oncocytic Schneiderian papilloma accompanied by intravascular lymphoma: A case report on FDG-PET/CT imaging
por: Koyama, Masamichi, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_07lk5k8jvk1dk6mb46f0nihpoj